RGEN
RGEN clinical trials: REPLIGEN CORP
Every trial on ClinicalTrials.gov where REPLIGEN CORP is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 10
- Trials linked
- 6
- As lead sponsor
- 4
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
RGEN on the catalyst calendar · RGEN registry changes
- Primary completion Dec 2010ActualPhase 2NCT00812058A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I DepressionRepligen Corporation · Bipolar I DepressionCompletedRGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2009ActualPhase 3NCT00660335Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the PancreasRepligen Corporation · PancreatitisCompletedRGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 2NCT00322764Phase II Study to Assess RG2417 in the Treatment of Bipolar I DepressionRepligen Corporation · Bipolar DepressionCompletedRGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 3NCT00036231Synthetic Human Secretin in Children With Autism and Gastrointestinal DysfunctionRepligen Corporation · AutismTerminatedRGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 1NCT00060515RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial DiseaseRepligen Corporation · Mitochondrial DiseasesTerminatedRGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 3NCT00036244Synthetic Human Secretin in Children With AutismRepligen Corporation · AutismCompletedRGENLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2006ActualPhase 2NCT00216294Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive DisorderIndiana University · Obsessive Compulsive Disorder (OCD)CompletedRGENCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2011Sponsor estimateEarly Phase 1NCT01371240Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor ConspicuityUniversity Hospitals Cleveland Medical Center · Pancreas CancerWithdrawnRGENCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 1NCT00076934Safety of RG2077 in Patients With Multiple SclerosisNational Institute of Allergy and Infectious Diseases (NIAID) · Multiple SclerosisCompletedRGENCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 2NCT00235274Effects of RG1068 (Secretin) on Information Processing in SchizophreniaIndiana University · SchizophreniaCompletedRGENCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 10 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner